The aim of this study is to develop a bioresponsive cisplatin (CDDP) delivery system with a self-assembling peptide amphiphile (PA) comprising a cell-adhesive matrix metalloproteinase-2 (MMP-2)-sensitive GTAGLIGQRGDS and a fatty acid. A biomimetic CDDP-PA gel was spontaneously formed upon incubating a mixture of CDDP and the PA for 5 h at 37 degrees C. CDDP-PA gel formation was confirmed by rheological analysis. The structure of self-assembled CDDP-PA nanofibers inside the gel was determined by transmission electron microscopy (TEM). Bioresponsive drug release from the biomimetic gel was demonstrated by in vitro MMP-2-triggered CDDP release. The MMP-2-sensitive CDDP release was dependent on the enzyme concentration in the medium. Enzymatic ...
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, pla...
Purpose To reduce the toxicity and achieve a sustainable and controllable release of cisplatin (C...
The development of anticancer drug delivery systems which retain or enhance the cytotoxic properties...
Novel cisplatin (CDDP)-loaded, polypeptide-based vesicles for the targeted delivery of cisplatin to ...
Novel cisplatin (CDDP)-loaded, polypeptide-based vesicles for the targeted delivery of cisplatin to ...
Peptide amphiphiles (PAs) self-assemble into supramolecular nanofiber gels that provide a suitable e...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of the...
A series of pH-responsive random copolymer poly(l-glutamic acid-co-L-lysine) [P(Glu-co-Lys)] were sy...
Controlling and guiding cell behavior requires scaffolding materials capable of programming the thre...
Four peptide amphiphiles (PA1-4) with different degrees of polymerization (DP = 40, 15, 10, and 6) w...
Antisense oligonucleotides provide a promising therapeutic approach for several disorders including ...
Jingping Liu1,2, Lanlan Zhang1, Zehong Yang1, Xiaojun Zhao1,31West China Hospital Laboratory of Nano...
The pH and reduction dual-responsive polypeptide nanogels with self-reinforced endocytoses were prep...
The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a ke...
Cancer metastasis is one of the major factors contributing to high mortality, and here we designed a...
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, pla...
Purpose To reduce the toxicity and achieve a sustainable and controllable release of cisplatin (C...
The development of anticancer drug delivery systems which retain or enhance the cytotoxic properties...
Novel cisplatin (CDDP)-loaded, polypeptide-based vesicles for the targeted delivery of cisplatin to ...
Novel cisplatin (CDDP)-loaded, polypeptide-based vesicles for the targeted delivery of cisplatin to ...
Peptide amphiphiles (PAs) self-assemble into supramolecular nanofiber gels that provide a suitable e...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of the...
A series of pH-responsive random copolymer poly(l-glutamic acid-co-L-lysine) [P(Glu-co-Lys)] were sy...
Controlling and guiding cell behavior requires scaffolding materials capable of programming the thre...
Four peptide amphiphiles (PA1-4) with different degrees of polymerization (DP = 40, 15, 10, and 6) w...
Antisense oligonucleotides provide a promising therapeutic approach for several disorders including ...
Jingping Liu1,2, Lanlan Zhang1, Zehong Yang1, Xiaojun Zhao1,31West China Hospital Laboratory of Nano...
The pH and reduction dual-responsive polypeptide nanogels with self-reinforced endocytoses were prep...
The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a ke...
Cancer metastasis is one of the major factors contributing to high mortality, and here we designed a...
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, pla...
Purpose To reduce the toxicity and achieve a sustainable and controllable release of cisplatin (C...
The development of anticancer drug delivery systems which retain or enhance the cytotoxic properties...